UV GERMI SA (ALUVI.PA) Fundamental Analysis & Valuation

EPA:ALUVI • FR0011898584

Current stock price

2.3 EUR
+0.02 (+0.88%)
Last:

This ALUVI.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. ALUVI.PA Profitability Analysis

1.1 Basic Checks

  • In the past year ALUVI was profitable.
  • ALUVI had positive earnings in 4 of the past 5 years.
  • In the past 5 years ALUVI always reported negative operating cash flow.
ALUVI.PA Yearly Net Income VS EBIT VS OCF VS FCFALUVI.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2023 2024 0 500K -500K

1.2 Ratios

  • The Return On Assets of ALUVI (5.27%) is better than 69.44% of its industry peers.
  • Looking at the Return On Equity, with a value of 5.80%, ALUVI is in line with its industry, outperforming 46.30% of the companies in the same industry.
  • With a Return On Invested Capital value of 3.15%, ALUVI is not doing good in the industry: 68.52% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA 5.27%
ROE 5.8%
ROIC 3.15%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALUVI.PA Yearly ROA, ROE, ROICALUVI.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2023 2024 0 5 -5 -10

1.3 Margins

  • With an excellent Profit Margin value of 7.75%, ALUVI belongs to the best of the industry, outperforming 80.56% of the companies in the same industry.
  • ALUVI's Profit Margin has improved in the last couple of years.
  • ALUVI has a Operating Margin of 5.61%. This is comparable to the rest of the industry: ALUVI outperforms 48.15% of its industry peers.
  • ALUVI has a Gross Margin of 51.20%. This is in the better half of the industry: ALUVI outperforms 70.37% of its industry peers.
  • ALUVI's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 5.61%
PM (TTM) 7.75%
GM 51.2%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y40.03%
GM growth 3Y3.79%
GM growth 5Y5.14%
ALUVI.PA Yearly Profit, Operating, Gross MarginsALUVI.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2023 2024 0 20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. ALUVI.PA Health Analysis

2.1 Basic Checks

  • ALUVI has about the same amout of shares outstanding than it did 1 year ago.
  • The number of shares outstanding for ALUVI has been increased compared to 5 years ago.
  • The debt/assets ratio for ALUVI has been reduced compared to a year ago.
ALUVI.PA Yearly Shares OutstandingALUVI.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2023 2024 1M 2M 3M
ALUVI.PA Yearly Total Debt VS Total AssetsALUVI.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

  • An Altman-Z score of 4.46 indicates that ALUVI is not in any danger for bankruptcy at the moment.
  • With an excellent Altman-Z score value of 4.46, ALUVI belongs to the best of the industry, outperforming 87.96% of the companies in the same industry.
  • A Debt/Equity ratio of 0.00 indicates that ALUVI is not too dependend on debt financing.
  • The Debt to Equity ratio of ALUVI (0.00) is better than 95.37% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 4.46
ROIC/WACCN/A
WACCN/A
ALUVI.PA Yearly LT Debt VS Equity VS FCFALUVI.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2023 2024 0 2M 4M 6M 8M

2.3 Liquidity

  • A Current Ratio of 7.88 indicates that ALUVI has no problem at all paying its short term obligations.
  • ALUVI has a Current ratio of 7.88. This is amongst the best in the industry. ALUVI outperforms 99.07% of its industry peers.
  • ALUVI has a Quick Ratio of 5.51. This indicates that ALUVI is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Quick ratio value of 5.51, ALUVI belongs to the best of the industry, outperforming 99.07% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 7.88
Quick Ratio 5.51
ALUVI.PA Yearly Current Assets VS Current LiabilitesALUVI.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2023 2024 2M 4M 6M 8M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. ALUVI.PA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 200.00% over the past year.
  • Measured over the past years, ALUVI shows a very strong growth in Earnings Per Share. The EPS has been growing by 42.53% on average per year.
  • The Revenue has decreased by -9.66% in the past year.
  • ALUVI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.64% yearly.
EPS 1Y (TTM)200%
EPS 3YN/A
EPS 5Y42.53%
EPS Q2Q%-26.67%
Revenue 1Y (TTM)-9.66%
Revenue growth 3Y10.44%
Revenue growth 5Y6.64%
Sales Q2Q%-22.1%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALUVI.PA Yearly Revenue VS EstimatesALUVI.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ALUVI.PA Yearly EPS VS EstimatesALUVI.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 0.1 0.2 0.3 0.4

More info and screens

Find the best growth stocksShow best growing peers

2

4. ALUVI.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • ALUVI is valuated correctly with a Price/Earnings ratio of 12.78.
  • ALUVI's Price/Earnings ratio is rather cheap when compared to the industry. ALUVI is cheaper than 85.19% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 27.87. ALUVI is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 12.78
Fwd PE N/A
ALUVI.PA Price Earnings VS Forward Price EarningsALUVI.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALUVI.PA Per share dataALUVI.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.3
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ALUVI.PA Dividend Analysis

5.1 Amount

  • No dividends for ALUVI!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ALUVI.PA Fundamentals: All Metrics, Ratios and Statistics

UV GERMI SA

EPA:ALUVI (4/17/2026, 7:00:00 PM)

2.3

+0.02 (+0.88%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)01-06
Earnings (Next)07-23
Inst Owners5.01%
Inst Owner ChangeN/A
Ins Owners35.42%
Ins Owner ChangeN/A
Market Cap5.59M
Revenue(TTM)7.48M
Net Income(TTM)580.00K
Analysts84.44
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 12.78
Fwd PE N/A
P/S 0.75
P/FCF N/A
P/OCF N/A
P/B 0.57
P/tB 0.66
EV/EBITDA N/A
EPS(TTM)0.18
EY7.83%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS3.08
BVpS4.01
TBVpS3.51
PEG (NY)N/A
PEG (5Y)0.3
Graham Number4.02906 (75.18%)
Profitability
Industry RankSector Rank
ROA 5.27%
ROE 5.8%
ROCE 4.29%
ROIC 3.15%
ROICexc 3.15%
ROICexgc 3.6%
OM 5.61%
PM (TTM) 7.75%
GM 51.2%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y40.03%
GM growth 3Y3.79%
GM growth 5Y5.14%
F-ScoreN/A
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 7.88
Quick Ratio 5.51
Altman-Z 4.46
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)200%
EPS 3YN/A
EPS 5Y42.53%
EPS Q2Q%-26.67%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-9.66%
Revenue growth 3Y10.44%
Revenue growth 5Y6.64%
Sales Q2Q%-22.1%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y75%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

UV GERMI SA / ALUVI.PA Fundamental Analysis FAQ

What is the fundamental rating for ALUVI stock?

ChartMill assigns a fundamental rating of 4 / 10 to ALUVI.PA.


What is the valuation status of UV GERMI SA (ALUVI.PA) stock?

ChartMill assigns a valuation rating of 2 / 10 to UV GERMI SA (ALUVI.PA). This can be considered as Overvalued.


How profitable is UV GERMI SA (ALUVI.PA) stock?

UV GERMI SA (ALUVI.PA) has a profitability rating of 4 / 10.


How financially healthy is UV GERMI SA?

The financial health rating of UV GERMI SA (ALUVI.PA) is 7 / 10.